PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 19, 2026Biomicrofluidics0 citations

Parallelized contactless microfluidic dispenser with superhydrophobic nozzles for scalable combinatorial screening

View Full Paper
NWNiphattha WongwisetMSMorgan L. StephensBQBlanca I. Quiñones-Díaz

Key Points

  • This work aims to develop a parallel combinatorial microfluidic system to improve sample generation for drug discovery.
  • Introduced a parallel combinatorial microfluidic (PCM) system with superhydrophobic outlets.
  • Utilized hydraulic-resistance networks for simultaneous combinatorial map generation.
  • Conducted antibiotic cell assays to evaluate biocompatibility and performance against standard methods.
  • Successfully generated predefined combinatorial maps within 5 minutes.
  • Produced droplets of 3.5 μl with minimal contamination.
  • Demonstrated results comparable to traditional methods, shown by overlapping IC50 ranges.

Abstract

While high-throughput combinatorial sample generation plays a critical role in drug discovery and cell-based assays, standard methods have encountered challenges of time or cost-effectiveness when using manual preparation or serial-dispensing liquid handlers. To address these challenges, we introduce a novel parallel combinatorial microfluidic (PCM) system that applies the design of hydraulic-resistance networks to simultaneously generate a prespecified combinatorial map. Unlike conventional serial dispensing, PCM devices integrated superhydrophobic outlets for parallel contactless dispensing, thereby minimizing contamination, reducing processing time, and ensuring an identical reaction time across all samples. Regardless of the number of target samples, the PCM system demonstrated rapid operation by completing all processes within 5 min. Devices fabricated for multiple combinatorial maps validated the PCM design principle and high-throughput scalability by reliably producing the predefined maps with droplet sizes of 3.5 μl. A proof-of-concept study of antibiotic cell assays confirmed the biocompatibility of the system and its ability to produce results comparable to those of standard methods, as demonstrated by good overlapping ranges of the half maximal inhibitory concentration (IC50). This work establishes a novel, cost-effective, high-throughput technology for combinatorial screenings in drug development with future improvements targeting sub-3.5 μl to enhance accuracy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wongwiset et al. (2026) studied this question.

synapsesocial.com/papers/69e47250010ef96374d8e73bhttps://doi.org/10.1063/5.0321277
Ask AI
Helpful
Bookmark
Share
View Full Paper